id int64 1 4.63k | registration_number stringlengths 14 21 ⌀ | code stringlengths 7 9 | inn stringlengths 4 193 | brand_name stringlengths 3 271 | form stringclasses 912
values | dosage stringlengths 2 289 ⌀ | packaging stringlengths 3 574 | list stringclasses 9
values | p1 stringclasses 4
values | p2 stringclasses 6
values | observation stringclasses 26
values | laboratory stringclasses 827
values | laboratory_country stringclasses 66
values | registration_date_initial stringdate 1996-05-15 00:00:00 2018-06-18 00:00:00 ⌀ | registration_date_final stringdate 1996-09-30 00:00:00 2018-12-31 00:00:00 ⌀ | type stringclasses 12
values | status stringclasses 13
values | shelf_life stringclasses 29
values | price_decision stringlengths 3 120 ⌀ | reimbursable stringclasses 4
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 352/15 F 099/16 | 15 F 099 | RIVASTIGMINE TARTRATE EXPRIME EN RIVASTIGMINE | RESTILON | SOLUTION BUV | 2MG/ML | B/1 FL DE 120ML | Liste I | HOP | OFF | null | EL KENDI INDUSTRIE DES MEDICAMENTS | ALGERIE | 2016-12-04 | 2016-12-04 | Ge | F | 24MOIS | PCSU 2907,20 DA | null |
2 | 035/01 A 003/17 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | GRIPEX ALLERGIE | COMP. PELLI.SEC. | 10MG | B/07 | Liste II | HOP | OFF | null | PHARMALLIANCE EURL | ALGERIE | 2017-09-10 | 2017-09-10 | Ge | F | 24 MOIS | PCSU 54,68 DA | OUI |
3 | 235/ 01 A 003 /16 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | RHITENE | COMP. PELLI. | 10MG | B/15 | Liste II | HOP | OFF | null | BIOGALENIC | ALGERIE | 2016-01-17 | 2016-01-17 | Ge | F | 24 MOIS | PCSU 117,18 DA | OUI |
4 | 352/ 01 A 003 /06/13 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | ARTIZ | COMP. PELLI. | 10MG | B/10 | Liste II | HOP | OFF | null | EL KENDI INDUSTRIE DU MEDICAMENT SPA | ALGERIE | 2006-07-31 | 2013-08-07 | Ge | F | 24 MOIS | PCSU 78,90 DA | OUI |
5 | 304/ 01 A 003 /04/17 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | HISTARIZINE | COMP.SEC. | 10MG | B/10 | Liste II | HOP | OFF | null | GEOPHARM SARL | ALGERIE | 2018-01-07 | 2018-01-07 | Ge | F | 24 MOIS | null | OUI |
6 | 380/ 01 A 003 /16 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | ZYRTIRIZINE | COMP. PELLI. SEC | 10MG | B/10 | Liste II | HOP | OFF | null | HUP.P.PHARMA SARL | ALGERIE | 2016-07-26 | 2016-07-26 | Ge | F | 24MOIS | PCSU 78,12 DA | OUI |
7 | 077/01 A 003/17 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | ZYTREX | COM SECABLE | 10MG | B/10 | Liste II | HOP | OFF | null | LAM | ALGERIE | 2017-01-17 | 2017-01-17 | Ge | F | 24 MOIS | PCSU 67,25 DA | OUI |
8 | 450/ 01 A 003 /07/13 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | CETIRIZINE MYLAN | COMP. PELLI.SEC. | 10MG | B/15 | Liste II | HOP | OFF | null | MYLAN SAS | FRANCE | 2007-04-22 | 2013-07-30 | Ge | I | 24 MOIS | FOB 1,21 € | OUI |
9 | 468/ 01 A 003 /15 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | NADEC | COMP. PELLI. SEC | 10MG | B/15 | Liste II | HOP | OFF | null | NADPHARMADIC PRODUCTION SARL | ALGERIE | 2015-12-02 | 2015-12-02 | Ge | F | 24 MOIS | PCSU 117,18 DA | OUI |
10 | 462/ 01 A 003 /13 | 01 A 003 | CETIRIZINE DICHLORHYDRATE | CETIRIZINE PHYSIOPHARM | COMP. PELLI. SEC. | 10MG | B/10 | Liste II | HOP | OFF | null | PHYSIOPHARM SARL | ALGERIE | 2013-05-12 | 2013-05-12 | Ge | F | 24 MOIS | PCSU 40,83 DA | OUI |
11 | 003/ 01 A 005 /97/17 | 01 A 005 | DEXCHLORPHENIRAMINE MALEATE | HISTAGAN | COMP. SEC. | 2MG | B/30 | null | HOP | OFF | null | EPE GROUPE INDUSTRIEL SAIDAL/SPA | ALGERIE | 1997-08-12 | 2017-09-04 | Ge | F | 36 MOIS | PCSU 66,67DA | OUI |
12 | 035/01 A 007/17 | 01 A 007 | DEXCHLORPHENIRAMINE MALEATE | FENIRAMINE | SIROP | 0,5 MG/5ML (0,01%) | b/01 fl de 125 ml +cuillere de mesue de 5 ml | Liste II | HOP | OFF | null | PHARMALLIANCE EURL | ALGERIE | 2017-08-03 | 2017-08-03 | Ge | F | 24 MOIS | PCSU 81,73 DA | null |
13 | 503/01 A 007/16 | 01 A 007 | DEXCHLORPHENIRAMINE MALEATE | DEXCHLORPHENIRAMINE AFRO | SOL BUVABLE | 0,5MG/5ML | F/125 ML+CUILLERE DE MESURE DE 5ML GRADUEE | Liste II | HOP | OFF | null | AFRO PHARM | ALGERIE | 2016-11-09 | 2016-11-09 | Ge | F | 24 MOIS | PCSU 81,73 DA | OUI |
14 | 088/ 01 A 007 /02 | 01 A 007 | DEXCHLORPHENIRAMINE MALEATE | DORAMINE | SIROP | 0,5MG/5ML | FL/125ML | Liste II | HOP | OFF | null | PHARMAGHREB | ALGERIE | 2002-03-16 | 2002-03-16 | Ge | F | null | null | OUI |
15 | 003/ 01 A 007 /97/17 | 01 A 007 | DEXCHLORPHENIRAMINE MALEATE EXPRIME EN DEXCHLORPHENIRAMINE | HISTAGAN | SIROP | 0,5MG/5ML(0,01 %) | FL/125ML | Liste II | HOP | OFF | null | EPE GROUPE INDUSTRIEL SAIDAL/SPA | ALGERIE | 1997-01-05 | 2017-12-04 | Ge | F | 36 MOIS | PCSU 81,73 DA | OUI |
16 | 065/01 A 007/17 | 01 A 007 | DEXCHLORPHENIRAMINE MALEATE | GENARITYNE | SIROP | 0,5MG/5ML(0,01 %) | FL./125ML | Liste II | HOP | OFF | null | GENERIC LAB | ALGERIE | 2017-06-12 | 2017-06-12 | Ge | F | 24 MOIS | PCSU 81,73 DA | OUI |
17 | 242/ 01 A 007 /08 | 01 A 007 | DEXCHLORPHENIRAMINE MALEATE | HISTONE | SIROP | 0,5MG/5ML | FL./100ML | Liste II | HOP | OFF | null | GROUPE SANTE | ALGERIE | 2008-05-17 | 2008-05-17 | Ge | F | 36 MOIS | PCSU 46,17 DA | OUI |
18 | 242/ 01 A 008 /09 | 01 A 008 | DOXYLAMINE SUCCINATE | DOMSTAL | SIROP | 6,25MG/5ML | FL./100ML | Liste II | HOP | OFF | null | GROUPE SANTE | ALGERIE | 2009-05-02 | 2009-05-02 | Ge | F | 36 MOIS | PCSU 74,92 DA | NON |
19 | 003/ 01 A 008 /98/17 | 01 A 008 | DOXYLAMINE SUCCINATE | SULAMINE | SIROP | 6,25MG/5ML | FL/125 ML | Liste II | HOP | OFF | null | EPE GROUPE INDUSTRIEL SAIDAL/SPA | ALGERIE | 1997-01-05 | 2017-10-08 | Ge | F | 36 MOIS | null | NON |
20 | 013/01 A 009/98/16 | 01 A 009 | MEQUITAZINE | NATAZINE | COMP. | 5MG | B/14 | Liste I | HOP | OFF | null | INDUSTRIA FARMACEUTICA NOVA ARGENTIA SPA | Italie | 1998-07-01 | 2017-03-05 | Ge | I | 36 MOIS | FOB 1,50 € | NON |
21 | 099/ 01 A 009 /98 | 01 A 009 | MEQUITAZINE | PRIMALAN | COMP. | 5MG | B/14 | Liste I | HOP | OFF | null | PIERRE FABRE | FRANCE | 1998-11-12 | 1998-11-12 | Re | I | null | null | NON |
22 | 487/ 01 A 011 /06/14 | 01 A 011 | PROMETHAZINE CHLORHYDRATE EXPRIME EN PROMETHAZINE | PRANOK | SOL. INJ. | 50MG/02ML | B/100 AMP. 02ML | Liste I | HOP | null | null | GLOBAL PHARMATECH PRIVATE LIMITED | INDE | 2006-07-22 | 2014-11-02 | Ge | I | 36 MOIS | FOB 18,00 $ | NON |
23 | 099/ 01 A 032 /07 | 01 A 032 | MEQUITAZINE | PRIMALAN | SIROP | 1,25MG/2,5ML | FL/60ML | null | HOP | OFF | null | PIERRE FABRE MEDICAMENT | FRANCE | 2007-07-22 | 2007-07-22 | Re | I | 36 MOIS | FOB 1,22 € | NON |
24 | 319/ 01 A 033 /08 | 01 A 033 | LORATADINE | GELARTINE | COMP. | 10MG | B/20 | Liste II | HOP | OFF | null | ARAB PHARM | ALGERIE | 2008-12-23 | 2008-12-23 | Ge | F | 36 MOIS | PCSU 213,66 DA | OUI |
25 | 293/ 01 A 033 /04/12 | 01 A 033 | LORATADINE | LUTEDINE | GLES. | 10MG | B/30 | Liste II | HOP | OFF | null | BIOCARE SARL | ALGERIE | 2004-11-10 | 2012-05-20 | Ge | Fpremix | 36 MOIS | PCSU 340,00 DA | OUI |
26 | 235/ 01 A 033 /09 | 01 A 033 | LORATADINE | RITADOLE | COMP. SEC. | 10MG | B/20 | Liste II | HOP | OFF | null | BIO-GALENIC | ALGERIE | 2009-07-19 | 2009-07-19 | Ge | F | 36 MOIS | PCSU 120,34 DA | OUI |
27 | 055/ 01 A 033 /01/11 | 01 A 033 | LORATADINE | LORATAN | COMP. | 10MG | B/30 | Liste II | HOP | OFF | null | DAR AL DAWA DEVELOPMENT & INVESTSMENT Co Ltd | JORDANIE | 2001-02-10 | 2011-10-12 | Ge | Fpremix | 36 MOIS | PCSU 315,00 DA | OUI |
28 | 242/ 01 A 033 /12 | 01 A 033 | LORATADINE | ORIN | COMP. | 10MG | B/10 | Liste II | HOP | OFF | null | GROUPE SANTE | ALGERIE | 2012-09-25 | 2012-09-25 | Ge | Fpremix | 36 MOIS | PCSU 33,33 DA | OUI |
29 | 001/ 01 A 033 /00/07 | 01 A 033 | LORATADINE | RESTAMINE | COMP. | 10MG | B/10 - B/20 | Liste II | HOP | OFF | null | HIKMA PHARMACEUTICALS | JORDANIE | 2000-11-18 | 2007-01-06 | Ge | F | 36 MOIS | PCSU 113,36 DA (B/10) ; PCSU 181,44 DA (B/20) | OUI |
30 | 447/ 01 A 033 /14 | 01 A 033 | LORATADINE | LORATADINE BEKER | COMP. | 10MG | B/30 | Liste II | HOP | OFF | null | LABORATOIRES BEKER SARL | ALGERIE | 2014-12-15 | 2014-12-15 | Ge | F | 24 MOIS | PCSU 133,51 DA | OUI |
31 | 268/ 01 A 033 /05/12 | 01 A 033 | LORATADINE | AKARYD | COMP. PELLI. | 10MG | B/20 | Liste II | HOP | OFF | null | MERINAL | ALGERIE | 2005-06-14 | 2012-11-11 | Ge | F | 36 MOIS | PCSU 180,00 DA | OUI |
32 | 418/ 01 A 033 /09/17 | 01 A 033 | LORATADINE | NEOTADINE | COMP. | 10MG | B/10 ET B/20 | Liste II | HOP | OFF | null | NEOMEDIC | ALGERIE | 2009-06-15 | 2017-01-09 | Ge | F | 36 MOIS | PCSU 104,80 DA | OUI |
33 | 149/ 01 A 033 /13 | 01 A 033 | LORATADINE | LORATADINE NOVAGENERICS | COMP. | 10MG | B/20 | Liste II | HOP | OFF | null | NOVAPHARM TRADING SARL | ALGERIE | 2013-09-09 | 2013-09-09 | Ge | F | 24 MOIS | PCSU 84,64 DA | OUI |
34 | 035/ 01 A 033 /98/13 | 01 A 033 | LORATADINE | LORADINE | COMP. | 10MG | B/20 | Liste II | HOP | OFF | null | PHARMALLIANCE EURL | ALGERIE | 1998-03-10 | 2013-08-19 | Ge | F | 36 MOIS | PCSU 84,54 DA | OUI |
35 | 003/ 01 A 033 /03/09 | 01 A 033 | LORATADINE | ALLERTINE | COMP. | 10MG | B/20 | Liste II | HOP | OFF | null | SAIDAL GROUPE | ALGERIE | 2003-08-13 | 2009-12-06 | Ge | F | 36 MOIS | PCSU 241,68 DA | OUI |
36 | 050/ 01 A 033 /02 | 01 A 033 | LORATADINE | TIRLOR | COMP | 10MG | B/20 | Liste II | HOP | OFF | null | SANDOZ SPA | ALGERIE | 2002-09-24 | 2002-09-24 | Ge | F | null | null | OUI |
37 | 039/ 01 A 033 /16 | 01 A 033 | LORATADINE | LORATAL | COMP | 10MG | B/20 | Liste II | HOP | OFF | null | SOPHAL SPA | ALGERIE | 2016-03-13 | 2016-03-13 | Ge | F | 24MOIS | PCSU 77,586 DA | OUI |
38 | 348/ 01 A 033 /08 | 01 A 033 | LORATADINE | APILOR | COMP. | 10MG | B/20 | Liste II | HOP | OFF | null | ALGERIAN PHARMACEUTICAL INSTITUT (API) | ALGERIE | 2008-09-10 | 2008-09-10 | Ge | F | 36 MOIS | PCSU 178,80 DA | OUI |
39 | 319/ 01 A 034 /08 | 01 A 034 | LORATADINE | GELARTINE | SIROP | 1MG/ML | FL./60ML | Liste II | HOP | OFF | null | ARAB PHARM | ALGERIE | 2008-12-23 | 2008-12-23 | Ge | F | 36 MOIS | PCSU 100,00 DA | OUI |
40 | 242/ 01 A 034 /09 | 01 A 034 | LORATADINE | ORIN | SIROP | 1MG/ML | FL./60ML | Liste II | HOP | OFF | null | GROUPE SANTE | ALGERIE | 2009-01-27 | 2009-01-27 | Ge | F | 36 MOIS | PCSU 71,65 DA | OUI |
41 | 001/ 01 A 034 /02 | 01 A 034 | LORATADINE | RESTAMINE | SIROP | 1MG/ML | FL./60ML | Liste II | HOP | OFF | null | HIKMA PHARMACEUTICALS | JORDANIE | 2002-09-04 | 2002-09-04 | Ge | F | null | null | OUI |
42 | 077/ 01 A 034 /05 | 01 A 034 | LORATADINE | HOCINOR | SIROP | 1MG/ML | F/125ML | Liste II | HOP | OFF | null | LABORATOIRE ALGERIEN DU MEDICAMENT (LAM) | ALGERIE | 2005-06-14 | 2005-06-14 | Ge | F | null | null | OUI |
43 | 003/ 01 A 034 /06 | 01 A 034 | LORATADINE | ALLERTINE | SIROP | 1MG/ML | FL./60ML | Liste II | HOP | OFF | null | SAIDAL GROUPE | ALGERIE | 2006-02-25 | 2006-02-25 | Ge | F | 36 MOIS | PCSU 96,97 DA | OUI |
44 | 317/ 01 A 034 /07 | 01 A 034 | LORATADINE | CLARDINE | SOL. BUV. | 1MG/ML | FL./60ML | Liste II | HOP | OFF | null | INPHA SPA | ALGERIE | 2007-11-18 | 2007-11-18 | Ge | F | 36 MOIS | PCSU 110,00 DA | OUI |
45 | 073/ 01 A 034 /07 | 01 A 034 | LORATADINE | CLARADINE | SOL. BUV. | 1MG/ML | FL./60ML | Liste II | HOP | OFF | null | ISOPHARM | ALGERIE | 2007-09-15 | 2007-09-15 | Ge | F | 36 MOIS | PCSU 70,00 DA | OUI |
46 | 035/ 01 A 034 /08 | 01 A 034 | LORATADINE | LORATADINE | SIROP | 1MG/ML | FL./100ML | Liste II | HOP | OFF | null | PHARMALLIANCE | ALGERIE | 2008-03-24 | 2008-03-24 | Ge | F | 36 MOIS | PCSU 98,02 DA | OUI |
47 | 447/01 A 039/17 | 01 A 039 | Fexofenadine chlorhydrate | FEXOFENADINE BEKER | COMP. PELLI. | 120MG | B/15 | Liste II | HOP | OFF | null | BEKER LABORATOIRES SARL | ALGERIE | 2017-02-12 | 2017-02-12 | Ge | F | 24 MOIS | PCSU 171,59 DA | OUI |
48 | 352/ 01 A 039 /07/17 | 01 A 039 | Fexofenadine chlorhydrate | FEXODINE | COMP. PELLI. | 120MG | B/15 | Liste II | HOP | OFF | null | EL KENDI INDUSTRIE DU MEDICAMENT | ALGERIE | 2007-05-09 | 2017-12-31 | Ge | F | 36 MOIS | PCSU 172,72 DA | OUI |
49 | 268/ 01 A 039 /07/12 | 01 A 039 | Fexofenadine chlorhydrate | RIFEX 120 | COMP. PELLI. | 120MG | B/20 | Liste II | HOP | OFF | null | MERINAL | ALGERIE | 2007-02-13 | 2012-09-25 | Ge | Fpremix | 36 MOIS | PCSU 229,17 DA | OUI |
50 | 149/ 01 A 039 /14 | 01 A 039 | Fexofenadine chlorhydrate | FEXOFENADINE NOVAGENERICS | COMP PELL | 120MG | B/15 | Liste II | HOP | OFF | null | NOVAPHARM TRADING SARL | ALGERIE | 2014-05-04 | 2014-05-04 | Ge | F | 36 MOIS | PCSU 171,60 DA | OUI |
51 | 195/ 01 A 039 /07/12 | 01 A 039 | Fexofenadine chlorhydrate | FEXOFENADINE IVAL | COMP.PELLI. | 120MG | B/15 | Liste II | HOP | OFF | null | PHARMA IVAL SPA | ALGERIE | 2007-05-12 | 2012-12-10 | Ge | F | 36 MOIS | PCSU 172,72 DA | OUI |
52 | 035/01 A 039/17 | 01 A 039 | Fexofenadine chlorhydrate | TELFADINE | COMP. PELLI. | 120MG | B/20 | Liste II | HOP | OFF | null | PHARMALLIANCE | ALGERIE | 2017-02-07 | 2017-02-07 | Ge | F | 24 MOIS | PCSU 230,29 DA | OUI |
53 | 392/ 01 A 039 /00/15 | 01 A 039 | Fexofenadine chlorhydrate | TELFAST | COMP PELLI. | 120MG | B/15 | Liste II | HOP | OFF | null | SANOFI AVENTIS ALGERIE SPA | ALGERIE | 2000-11-18 | 2006-06-07 | Re | Fpremix | 36 MOIS | PCSU 171,59 DA | OUI |
54 | 039/ 01 A 039 /11/17 | 01 A 039 | Fexofenadine chlorhydrate | FEXONIDAL | COMP. PELLI. | 120MG | B/15 | Liste II | HOP | OFF | null | SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL) | ALGERIE | 2011-09-20 | 2017-04-12 | Ge | F | 24 MOIS | PCSU 211,36 DA | OUI |
55 | 492/ 01 A 039 /15 | 01 A 039 | Fexofenadine chlorhydrate | FASTOFEN 120 | COMP. PELLI. | 120MG | B/20 | Liste II | HOP | OFF | null | SOPRODIM SPA | ALGERIE | 2015-07-26 | 2016-02-02 | Ge | F | 24 MOS | PCSU 218,96 DA | OUI |
56 | 352/ 01 A 040 /07/17 | 01 A 040 | Fexofenadine chlorhydrate | FEXODINE | COMP. PELLI. | 180MG | B/15 | Liste II | HOP | OFF | null | EL KENDI INDUSTRIE DU MEDICAMENT | ALGERIE | 2007-05-09 | 2017-12-27 | Ge | F | 36 MOIS | PCSU 202,90 DA | OUI |
57 | 268/ 01 A 040 /07/12 | 01 A 040 | Fexofenadine chlorhydrate | RIFEX 180 | COMP. PELLI. | 180MG | B/20 | Liste II | HOP | OFF | null | MERINAL | ALGERIE | 2007-02-13 | 2012-09-25 | Ge | Fpremix | 36 MOIS | PCSU 270,53 DA | OUI |
58 | 392/ 01 A 040 /00/15 | 01 A 040 | Fexofenadine chlorhydrate | TELFAST | COMP PELLI. | 180MG | B/15 | Liste II | HOP | OFF | null | SANOFI AVENTIS ALGERIE SPA | ALGERIE | 2000-11-18 | 2015-06-24 | Re | Fpremix | 36 MOIS | PCSU 202,61 DA | OUI |
59 | 039/ 01 A 040 /11/18 | 01 A 040 | Fexofenadine chlorhydrate | FEXONIDAL | COMP. PELLI. | 180MG | B/15 | Liste II | HOP | OFF | null | SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL) | ALGERIE | 2011-09-20 | 2018-06-05 | Ge | F | 24 MOIS | PCSU 217,00 DA | OUI |
60 | 492/ 01 A 040 /15 | 01 A 040 | Fexofenadine chlorhydrate | FASTOFEN 180 | COMP. PELLI. | 180MG | B/20 | Liste II | HOP | OFF | null | SOPRODIM SPA | ALGERIE | 2015-03-31 | 2016-02-02 | Ge | F | 24 MOIS | PCSU 257,51 DA | OUI |
61 | 447/01 A 040/17 | 01 A 040 | Fexofenadine chlorhydrate | FEXOFENADINE BEKER | COMP. PELLI. | 180MG | B/20 | Liste II | HOP | OFF | null | BEKER LABORATOIRES SARL | ALGERIE | 2017-02-07 | 2017-02-07 | Ge | F | 24 MOIS | PCSU 205,80 DA | OUI |
62 | 195/ 01 A 040 /07/14 | 01 A 040 | Fexofenadine chlorhydrate | FEXOFENADINE IVAL | COMP. PELLI. SEC. | 180MG | B/15 | Liste II | HOP | OFF | null | PHARMA IVAL SPA | ALGERIE | 2007-05-12 | 2014-10-13 | Ge | F | 36 MOIS | PCSU 202,62 DA | OUI |
63 | 149/ 01 A 040 /15 | 01 A 040 | Fexofenadine chlorhydrate | FEXOFENADINE NOVAGENERICS | COMP. PELLI. | 180MG | B/15 | Liste II | HOP | OFF | null | SARL NOVAPHARM TRADING | ALGERIE | 2015-12-02 | 2015-12-02 | Ge | F | 24 MOIS | PCSU 202,61 DA | OUI |
64 | 235/ 01 A 041 /14 | 01 A 041 | CETIRIZINE DICHLORHYDRATE | RHITENE | SOL BUV EN GTTES | 10MG/ML | B/01FL COMPTE GTTES DE 15ML | Liste II | HOP | OFF | null | BIOGALENIC | ALGERIE | 2014-04-15 | 2014-04-15 | Ge | F | 24 MOIS | PCSU 333,66 DA | OUI |
65 | 352/01 A 041/16 | 01 A 041 | CETIRIZINE DICHLORHYDRATE | ARTIZ | SOL BUV EN GTTES | 10MG/ML | B /FL 30ML +PIPETTE GRADUEE | Liste II | HOP | OFF | null | EL KENDI PHARMACEUTICALS MANUFACTURING COMPANY | ALGERIE | 2016-12-04 | 2016-12-04 | Ge | F | 24MOIS | PCSU 362,73 DA | OUI |
66 | 065/01 A 041/17 | 01 A 041 | CETIRIZINE DICHLORHYDRATE | CETIRIZINE GL | SOL BUV EN GTTES | 10MG/ML | B/1 FL DE 15 ML +01 SERINGUE DOSEUSE | Liste II | HOP | OFF | null | GENERICLAB SARL | ALGERIE | 2017-02-27 | 2017-02-27 | Ge | F | 24 MOIS | PCSU 247,77 DA | OUI |
67 | 046/ 01 A 041 /02 | 01 A 041 | CETIRIZINE DICHLORHYDRATE | ZYRTEC | SOL BUV.GTTES | 10MG/ML | B/01FL COMPTE GTTES DE 15ML | Liste II | HOP | OFF | null | UCB PHARMA | FRANCE | 2002-09-04 | 2002-09-04 | Ge | I | null | null | OUI |
68 | 285/ 01 A 041 /13 | 01 A 041 | CETIRIZINE DICHLORHYDRATE | ZETIREC | SOL. BUV. GTTES. | 10MG/ML | B/01FL COMPTE GTTES DE 15ML | Liste II | HOP | OFF | null | UNION PHARMACEUTIQUE CONSTANTINOISE (UPC) | ALGERIE | 2013-08-07 | 2013-08-07 | Ge | F | 24 MOIS | PCSU 412,06 DA | OUI |
69 | 352/ 01 A 043 /09 | 01 A 043 | RUPATADINE FUMARATE EXPRIME EN RUPATADINE | RUPAFIN | COMP. | 10MG | B/20 | Liste II | HOP | OFF | null | EL KENDI PHARMACEUTICALS MANUFACTURING COMPANY | ALGERIE | 2009-02-04 | 2009-02-04 | Ge | I | 36 MOIS | FOB 11,00 $ | NON |
70 | 406/ 01 A 044 /08/16 | 01 A 044 | DIPHENHYDRAMINE CHLORHYDRATE | HUDU | COMP. SEC. | 50MG | B/20 | null | HOP | OFF | null | BEIT JALA PHARMACEUTICALS Co | PALESTINE | 2008-12-22 | 2016-07-10 | Ge | I | 36 MOIS | FOB 2,25 $ | NON |
71 | 318/01 A 047/17 | 01 A 047 | Desloratadine | DESLORAL | COMP. PELLI. | 5MG | B/30 ET B/15 | Liste II | HOP | OFF | null | PHARMIDAL N.S. SARL | ALGERIE | 2017-07-30 | 2017-07-30 | Ge | F | 24 MOIS | null | OUI |
72 | 293/01 A 047/17 | 01 A 047 | Desloratadine | UDINE | COMP. PELLI. | 5MG | B/10 B/15 B /30 | Liste II | HOP | OFF | null | BIOCARE SARL | ALGERIE | 2017-03-19 | 2017-03-19 | Ge | F | 24 MOIS | PCSU B/30 640,00 DA B/15 PCSU 340,50 DA B/10 PCSU 227,00 DA | OUI |
73 | 352/ 01 A 047 /12/17 | 01 A 047 | Desloratadine | AIRDITINE | COMP. PELLI. | 5MG | B/10 | Liste II | HOP | OFF | null | EL KENDI INDUSTRIE DU MEDICAMENT | ALGERIE | 2012-03-29 | 2017-12-31 | Ge | F | 24 MOIS | PCSU 227,00 DA | NON |
74 | 317/ 01 A 047 /11 | 01 A 047 | Desloratadine | DESLOR | COMP. PELLI. | 5MG | B/15 ET B/30 | Liste II | HOP | OFF | null | INPHA-MEDIS | ALGERIE | 2011-05-30 | 2011-05-30 | Ge | F | 36 MOIS | PCSU 340,00 DA (B/15) ; PCSU 640,00 DA (B/30) | NON |
75 | 035/01 A 047/17 | 01 A 047 | Desloratadine | LORADESS | COMP. PELLI. | 5MG | B/10 | Liste II | HOP | OFF | null | PHARMALLIANCE EURL | ALGERIE | 2017-03-12 | 2017-03-12 | Ge | F | 24 MOIS | PCSU 227,00 DA | OUI |
76 | 352/ 01 A 048 /12/17 | 01 A 048 | Desloratadine | AIRDITINE | SIROP | 0,5MG/ML | B/1FL. DE 120ML + BOUCHON DOSEUR GRADUE | Liste II | HOP | OFF | null | EL KENDI INDUSTRIE DU MEDICAMENT | ALGERIE | 2012-03-29 | 2017-12-31 | Ge | F | 24 MOIS | PCSU 280,00 DA | OUI |
77 | 317/ 01 A 048 /11 | 01 A 048 | Desloratadine | DESLOR | SIROP | 0,5MG/ML | B/1FL. DE 150ML + UNE SERING. MESURE GRADUEE | Liste II | HOP | OFF | null | INPHA-MEDIS | ALGERIE | 2011-06-14 | 2011-06-14 | Ge | F | 36 MOIS | PCSU 350,00 DA | OUI |
78 | 035/ 01 A 048 /15 | 01 A 048 | Desloratadine | LORADESS | SIROP | 0,5ML/ML | B/1FL DE 120 ML + PIPETTE GRADUeE EN ML | Liste II | HOP | OFF | null | PHARMALLIANCE EUR L | ALGERIE | 2015-12-27 | 2015-12-27 | Ge | F | 24 MOIS | PCSU 279,77 DA | OUI |
79 | 001/ 01 A 049 /12 /17 | 01 A 049 | Bilastine | BILAXTEN | COMP. SEC. | 20MG | B/10 ET B/20 | Liste II | HOP | OFF | null | HIKMA PHARMA ALGERIA SARL | ALGERIE | 2012-03-20 | 2017-09-26 | Re | F | 36 MOIS | PCSU 377,65 DA (B/10) ; PCSU 756,44 DA (B/20) | NON |
80 | 149/01 A 050/17 | 01 A 050 | Fexofenadine chlorhydrate | FEXOFENADINE NOVAGENERICS | COMP. PELLI. | 30MG | B/30 | Liste II | HOP | OFF | null | NOVAPHARM TRADING SARL | ALGERIE | 2017-04-12 | 2017-04-12 | Ge | F | 24 MOIS | PCSU 169,34 DA | null |
81 | 392/ 01 A 050 /14 | 01 A 050 | Fexofenadine chlorhydrate | TELFAST | COMP. PELLI. | 30MG | B/30 | Liste II | HOP | OFF | null | SANOFI AVENTIS ALGERIE SPA | ALGERIE | 2014-11-25 | 2014-11-25 | Re | Fpremix | null | null | NON |
82 | 099/ 01 A 051 /13 | 01 A 051 | MEQUITAZINE | PRIMALAN | COMP. SEC. | 10MG | B/14 | Liste I | HOP | OFF | null | PIERRE FABRE MEDICAMENT | FRANCE | 2013-02-04 | 2013-02-04 | Re | I | 24 MOIS | FOB 2,00 € | NON |
83 | 400/01 A 053/17 | 01 A 053 | CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE | PERIAMEX | SIROP | 2MG/5ML | FL/100 ML | null | HOP | OFF | null | KPMA SARL | ALGERIE | 2017-01-09 | 2017-01-09 | Ge | F | 24 MOIS | PCSU 64,60 DA | NON |
84 | 079/ 01 A 053 /15 | 01 A 053 | CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE | HEPTAFORT | SIROP | 2MG/5ML | FL./125ML | null | HOP | OFF | null | LABORATOIRE ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE (LAD PHARMA) | ALGERIE | 2015-03-03 | 2015-03-03 | Ge | F | 24 MOIS | PCSU 71,85 DA | NON |
85 | 293/ 01 A 054 /15 | 01 A 054 | LeVOCeTIRIZINE DICHLORHYDRATE | XYCARE | COMP. PELLI. | 5 MG | B/14 ET B/28 | Liste II | HOP | OFF | null | BIOCARE SARL | ALGERIE | 2015-12-02 | 2015-12-02 | Ge | F | 24 MOIS | PCSU 190,48 DA PCSU 382,16 DA | NON |
86 | 418/01 A 054/17 | 01 A 054 | LeVOCeTIRIZINE DICHLORHYDRATE | LEVOZEN | COMP. PELLI. | 5 MG | B/14 ET B/28 | Liste II | HOP | OFF | null | NEOMEDIC | ALGERIE | 2017-02-07 | 2017-02-07 | Ge | F | 24 MOIS | PCSU B/14 190,48 DA B/28 382,16 DA | null |
87 | 457/ 01 A 055 /16 | 01 A 055 | CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE | CIPROMINE | COMP. | 4MG | B/30 | null | HOP | OFF | null | SOMEDIAL SPA | ALGERIE | 2016-01-10 | 2016-01-10 | Ge | F | 36 MOIS | PCSU 96,50 DA | OUI |
88 | 268/01 A 056/17 | 01 A 056 | EBASTINE | EBASTA | CP ORODISPERSIBLE | 10 MG | B/10 ET DE B/30 | LISTE II | HOP | OFF | null | MERINAL SPA | ALGERIE | 2017-06-12 | 2017-06-13 | Ge | F PREMIX | 24 MOIS | null | null |
89 | 130/ 01 D 029 /00/14 | 01 D 029 | EXTRAITS ALLERGENIQUES DERMATOPHAGOIDES PTERONYSSINUS | ALUSTAL | SUSP. INJ. | 0,1IR/ML+1IR/ML+10IR/ML | B/03FL. | null | HOP | OFF | null | STALLERGENES S.A. | FRANCE | 2000-03-19 | 2014-09-01 | Re | I | 12 MOIS | FOB 16,956 € | OUI |
90 | 130/ 01 D 030 /00/14 | 01 D 030 | EXTRAITS ALLERGENIQUS DERMATOPHAGOIDES PTERONYSSINUS | ALUSTAL | SUSP. INJ. | 10IR/ML | B/01 FL. | null | HOP | OFF | null | STALLERGENES S.A. | FRANCE | 2000-03-19 | 2014-09-01 | Re | I | 12 MOIS | FOB 11,592 € | OUI |
91 | 130/ 01 D 037 /00/14 | 01 D 037 | EXTRAITS ALLERGENIQUES MELANGE DE 5 GRAMINES | ALUSTAL | SUSP. INJ. | 0,1IR/ML+1IR/ML+10IR/ML | B/03FL. | null | HOP | OFF | null | STALLERGENES S.A. | FRANCE | 2000-03-19 | 2014-09-01 | Re | I | 12 MOIS | FOB 16,956 € | OUI |
92 | 130/ 01 D 038 /00/14 | 01 D 038 | EXTRAITS ALLERGENIQUES MELANGE DE 5 GRAMINES | ALUSTAL | SUSP. INJ. | 10IR/ML | B/01 FL. | null | HOP | OFF | null | STALLERGENES S.A. | FRANCE | 2000-03-19 | 2014-09-01 | Re | I | 12 MOIS | FOB 11,592 € | OUI |
93 | 130/ 01 D 052 /15 | 01 D 052 | EXTRAITS ALLERGENIQUES DERMARTOPHAGOIDES PTERONYSSINUS / DERMATOPHAGOIDES FARINEA (50/50) | STALORAL | SOLUTION SUBLINGUALE D'UN MELANGE D'EXTRAITS ALLERGENIQUE POUR IMMUNOTHERAPIE SPECIFIQUE | 10+100+300 IR/ML - 300 IR/ML | COFFRET DE 03 FL. DE 10ML DE SOLUTION (10+100+300 IR/ML) - COFFRET DE 01 FL. DE 10ML DE SOLUTION (300 IR/ML) | null | HOP | OFF | null | STALLERGENES S.A. | FRANCE | 2015-06-18 | 2015-06-18 | Re | I | 36 MOIS | FOB 25,00 € (COFFRET DE 03 FL.) ; FOB 21,00 € (COFFRET DE 01 FL.) | NON |
94 | 095/ 02 A 001 /98 | 02 A 001 | ALFENTANYL | RAPIFEN | SOL.INJ. | 1MG/2ML | B/05 | Stupefiants | HOP | null | null | JANSSEN CILAG | FRANCE | 1998-04-29 | 1998-04-29 | Re | I | null | null | NON |
95 | 095/ 02 A 002 /08/15 | 02 A 002 | FENTANYL CITRATE EXPRIME EN FENTANYL | FENTANYL JANSSEN | SOL.INJ. | 0,05MG/ML (0,5MG/10ML) | B/10AMP. DE 10ML | Stupefiants | HOP | null | null | JANSSEN CILAG | FRANCE | 2008-02-20 | 2015-12-29 | Re | I | 36 MOIS | FOB 5,91 € | NON |
96 | 095/02 A 001/98/16 | 02 A 002 | FENTANYL CITRATE EXPRIME EN FENTANYL | FENTANYL JANSSEN | SOL.INJ. | 0,1MG/AMP. | B/5 | Stupefiants | HOP | null | null | JANSSEN CILAG | FRANCE | 1998-04-20 | 2016-09-11 | Re | I | null | null | NON |
97 | 095/ 02 A 041 /99/15 | 02 A 041 | SUFENTANIL CITRATE EXPRIME EN SUFENTANIL | SUFENTA | SOL INJ IV OU PERIDURALE | 250µG/5ML | B/10AMP. DE 5ML | Stupefiants | HOP | null | null | JANSSEN CILAG | FRANCE | 1999-06-06 | 2015-03-18 | Re | I | 36 MOIS | FOB 31,52 € | NON |
98 | 095/ 02 A 050 /98 | 02 A 050 | ALFENTANYL | RAPIFEN | SOL.INJ. | 5MG/10ML | B/10 | Stupefiants | HOP | null | null | JANSSEN CILAG | FRANCE | 1998-04-29 | 1998-04-29 | Re | I | null | null | NON |
99 | 095/ 02 A 055 /05/16 | 02 A 055 | SUFENTANIL CITRATE EXPRIME EN SUFENTANIL | SUFENTA | SOL INJ IV OU PERIDURALE | 5µG/ML (10µG/2ML - 50µG/10ML) | B/5AMP. DE 2ML - B/10AMP.DE 10ML | Stupefiants | HOP | null | null | JANSSEN CILAG | FRANCE | 2005-09-28 | 2016-04-25 | Re | I | 36 MOIS | FOB 1,27€ (B/2) 10,24€ (B/10) | NON |
100 | 450/ 02 A 062 /15 | 02 A 062 | CHLORHYDRATE DE REMIFENTANIL | REMIFENTANIL MYLAN | POUDRE POUR SOL INJ OU POUR PERF IV | 2MG/ FLACON | BOITE DE 10 FLACONS DE 5 ML | Stupefiants | HOP | null | null | MYLAN SAS | France | 2015-12-02 | 2015-12-02 | Ge | I | 36 MOIS | FOB 32,40 | null |
🇩🇿 Algerian Drug Nomenclature — Nomenclature Nationale des Médicaments
A clean, structured, PII-free reference dataset of pharmaceutical products authorised for the Algerian market, derived from the official Nomenclature Nationale des Médicaments (Ministère de la Santé, Algeria).
This is reference product data — registration numbers, INNs, brand names, dosages, manufacturers, and reimbursement status. It contains no personal, patient, or transactional data of any kind.
Published by TKAWEN as part of our open-data program: well-curated, openly licensed datasets for Algerian and Maghrebi AI.
📊 At a glance
| Records | 4,627 registered products |
| Distinct INNs (active substances) | 1,365 |
| Manufacturers / decision holders | 827 |
| Reimbursable (CNAS/CASNOS) | 3,268 |
| Format | single UTF-8 CSV |
| PII | none |
🧬 Schema
| Column | Description |
|---|---|
id |
Row identifier |
registration_number |
National registration number (numéro d'enregistrement) |
code |
Nomenclature code |
inn |
International Non-proprietary Name — the active substance (DCI) |
brand_name |
Commercial brand name (nom de marque) |
form |
Galenic form (tablet, syrup, injection…) |
dosage |
Strength / concentration |
packaging |
Conditioning (conditionnement) |
list |
Regulatory list (Liste I / Liste II…) |
p1, p2 |
Dispensing setting flags (HOP = hospital, OFF = officine/pharmacy) |
observation |
Free-text notes |
laboratory |
Holder of the registration decision |
laboratory_country |
Country of the holder laboratory |
registration_date_initial |
Initial registration date |
registration_date_final |
Latest registration date |
type |
Product type (e.g. Ge = generic) |
status |
Registration status |
shelf_life |
Stated stability / shelf life |
price_decision |
Price carried on the registration decision |
reimbursable |
Reimbursement eligibility (OUI / blank) |
🚀 Usage
from datasets import load_dataset
ds = load_dataset("tkawen/algerian-drug-nomenclature", split="train")
print(ds[0])
# e.g. every reimbursable generic
generics = ds.filter(lambda r: r["type"] == "Ge" and r["reimbursable"] == "OUI")
import pandas as pd
df = pd.read_csv("hf://datasets/tkawen/algerian-drug-nomenclature/algerian_drug_nomenclature.csv")
df.groupby("inn").size().sort_values(ascending=False).head(20)
💡 Intended uses
- Pharmacy & health-tech software — drug autocomplete, code/INN lookup, CHIFA/CNAS-compatible product references.
- Pharmacovigilance & research — generic-vs-brand mapping, manufacturer landscape, reimbursement analysis.
- NLP for the Maghreb — entity normalisation of Algerian drug names (FR/AR), retrieval and matching.
- Education — a real, well-shaped tabular dataset for teaching.
⚠️ Limitations & responsible use
- This is a historical snapshot of the national nomenclature, not a live regulatory feed. Registration status, prices, and reimbursement can change. Always verify against the current official source before any clinical, dispensing, or billing decision.
- Prices are as carried on the registration decision and are not a real-time market price.
- Not medical advice. Not a substitute for the prescriber, the pharmacist, or official CNAS/CASNOS rules.
📜 Source & license
- Primary source: Nomenclature Nationale des Médicaments — Ministère de la Santé, République Algérienne (official public nomenclature).
- Cleaned, normalised, and re-published with English column names by TKAWEN.
- License: CC BY 4.0 — free to use with attribution.
🔒 Privacy
By design this dataset is reference product data only. It contains no patient data, no prescriptions, no transactions, and no personal information. This reflects TKAWEN's core principle: anonymized features and reference data, never PII.
TKAWEN · Engineering Trust · Empowering Minds · Algeria 🇩🇿 → Maghreb → World
- Downloads last month
- 32